The continuous progress of laboratory medicine now allows us to accurately verify the body’s immune response to evaluate the effectiveness of vaccination in humans. Not only to discover the presence of viruses and antibodies, therefore, but the entire immune response with respect to the disease and vaccination against Covid 19. “In cancer patients or in those affected by autoimmune diseases this verification is very important”, explains Tommaso Trenti, president of Sibioc (Italian Society of Clinical Biochemistry and Clinical Molecular Biology-Laboratory Medicine) and director of the Department of Laboratory Medicine and Pathological Anatomy of the Aou of Modena. “Our work allows us to indicate to clinicians what the patient’s real immune status is, to predict how he will react to chemotherapy, use of cortisone or immunosuppressive drugs. This is true today for Covid 19 but it can spread to other diseases, both viral than bacterial, for an ever greater protection of the patient “.
“This is one of the key issues that we will discuss during this year’s congress – he continues – underlining how the master letter given by Professor Alessio Fasano, an illustrious Harvard University clinician, focuses on how 21st century medicine is for diagnosis and treatment that for prevention will be based on laboratory medicine “.
“The Covid-19 epidemic was a frontier for all medical branches, but for us it was a real watershed – adds Laura Sciacovelli, past president of Sibioc and biologist manager at the Padua hospital -. The strategic role laboratory tests emerged clearly and sees our scientific society at the forefront in protecting the patient’s health by transferring diagnostic innovation to clinical practice. We indicate the most effective tests to assess the health of the individual “.
The introduction of new and increasingly advanced tests and genomics, the branch of molecular biology that deals with the study of the genome – continues the note – allow us to understand the effectiveness of new drugs and the development of personalized treatments. “Genomics provides us with the tools to enable precision medicine, a revolutionary approach in laboratory medicine and diagnostics, increasingly focused on understanding the expression of a single patient on its molecular configuration – explains the president-elect Sibioc Marcello Ciaccio, full professor of Biomedicine, neuroscience and advanced diagnostics at the University of Palermo – It is the topic of the master’s reading of this year’s congress, it describes how laboratory medicine will allow us to understand the individual in his uniqueness, with a clear advantage both for the patient, who will be treated with the most suitable drugs for his situation, and for the NHS who will obtain savings in the choice of high-cost treatments. Today, laboratory medicine is able to identify the biomarkers that allow the development of therapies targeted “.
But Sibioc – concludes the note – is not engaged only on the front of increasingly advanced tests to create precision medicine that increasingly protects the patient, but also on the institutional side, stimulating a continuous dialogue between the national health system and the Regions and healthcare companies.
“We try to give our contribution to select effective tests and eliminate those deemed useless – concludes Trenti – to find optimal prevention and clinical diagnostic therapeutic paths thanks to the innovation of new laboratory tests in precision medicine. The image of the Genoa bridge as a rebirth after a tragic event is the symbol of the congress to mark an important opportunity for recovery in the presence of activities and relationships. It is a unique moment for society to rebuild and strengthen the value and perception of the scientific community and professionalism that has always characterized us after the isolation of the pandemic season “.
#Trenti #Sibioc #innovative #tests #evaluate #effectiveness #antiCovid #vaccines